|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12Q 1/6886 | (2018.01) |
| (11) | Number of the document | 3268493 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16713202.6 |
| Date of filing the European patent application | 2016-03-11 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation | 2022-03-10 |
| (86) | Number | PCT/US2016/022004 |
| Date | 2016-03-11 |
| (87) | Number | WO 2016/145308 |
| Date | 2016-09-15 |
| (30) | Number | Date | Country code |
| 201562132064 P | 2015-03-12 | US |
| (72) |
RICCI, Deborah , US
GORMLEY, Michael , US
THOMAS, Shibu , US
RAJPUROHIT, Yashoda , US
SCHAFFER, Michael , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Viso kraujo mRNR žymenys, skirti prostatos vėžio prognozavimui, ir jo nustatymo būdai |
| WHOLE BLOOD BASED MRNA MARKERS FOR PREDICTING PROSTATE CANCER AND METHODS OF DETECTING THE SAME |
| Payment date | Validity (years) | Amount | |
| 2022-02-18 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-11 |